CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 55 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $14,409,000 | +59.1% | 2,150,641 | 0.0% | 0.42% | +47.2% |
Q2 2022 | $9,054,000 | +24.9% | 2,150,641 | 0.0% | 0.28% | +95.9% |
Q1 2022 | $7,247,000 | -46.5% | 2,150,641 | -50.0% | 0.14% | +39.4% |
Q4 2021 | $13,548,000 | +92.6% | 4,301,282 | +100.0% | 0.10% | +2.0% |
Q3 2021 | $7,033,000 | -61.3% | 2,150,641 | -50.0% | 0.10% | -13.6% |
Q2 2021 | $18,150,000 | +69.1% | 4,301,282 | +100.0% | 0.12% | -13.2% |
Q1 2021 | $10,731,000 | -60.5% | 2,150,641 | 0.0% | 0.14% | -53.4% |
Q4 2020 | $27,184,000 | +28.7% | 2,150,641 | 0.0% | 0.29% | -5.2% |
Q3 2020 | $21,119,000 | -1.3% | 2,150,641 | 0.0% | 0.31% | -11.2% |
Q2 2020 | $21,398,000 | +9.5% | 2,150,641 | 0.0% | 0.35% | -31.8% |
Q1 2020 | $19,549,000 | -1.5% | 2,150,641 | 0.0% | 0.51% | +29.2% |
Q4 2019 | $19,840,000 | +53.8% | 2,150,641 | -2.0% | 0.39% | +13.2% |
Q3 2019 | $12,904,000 | -51.2% | 2,194,641 | -0.5% | 0.35% | -42.7% |
Q2 2019 | $26,456,000 | -0.6% | 2,204,641 | 0.0% | 0.61% | -19.2% |
Q1 2019 | $26,610,000 | +16.6% | 2,204,641 | +17.7% | 0.75% | -13.6% |
Q4 2018 | $22,823,000 | +5752.1% | 1,873,779 | +8926.8% | 0.87% | +5331.2% |
Q3 2015 | $390,000 | – | 20,758 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |